Published in Am J Kidney Dis on June 24, 2008
YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation. J Biol Chem (2009) 0.97
Role of electron microscopy in the diagnosis of cadasil syndrome: a study of 32 patients. PLoS One (2013) 0.80
Notch in fibrosis and as a target of anti-fibrotic therapy. Pharmacol Res (2016) 0.79
High frequency of exon 10 mutations in the NOTCH3 gene in Italian CADASIL families: phenotypic peculiarities. J Neurol (2010) 0.78
A CADASIL-Like Case with a Novel Noncysteine Mutation of the NOTCH3 Gene and Granular Deposits in the Renal Arterioles. Case Rep Neurol Med (2015) 0.75
Weighing of biomolecules, single cells and single nanoparticles in fluid. Nature (2007) 6.42
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med (2011) 6.34
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med (2007) 5.84
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol (2005) 5.64
Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med (2008) 3.66
Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med (2011) 3.17
Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet (2004) 2.82
FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet (2012) 2.74
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med (2011) 2.64
Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol (2008) 2.64
Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol (2008) 2.60
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. Nephrol Dial Transplant (2008) 2.42
Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis (2002) 2.41
Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol (2012) 2.21
COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med (2007) 2.02
Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol (2013) 1.94
Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) (2009) 1.81
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant (2012) 1.80
Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrol (2012) 1.69
Acute renal infarction: a case series. Clin J Am Soc Nephrol (2012) 1.68
A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol (2007) 1.66
Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisited. Respir Med (2012) 1.61
Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol (2011) 1.57
IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore) (2012) 1.54
INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy. N Engl J Med (2011) 1.53
Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J Immunol (2006) 1.51
Chronic lithium nephropathy: MR imaging for diagnosis. Radiology (2003) 1.45
Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? Medicine (Baltimore) (2015) 1.45
Monitoring of heparin and its low-molecular-weight analogs by silicon field effect. Proc Natl Acad Sci U S A (2006) 1.45
Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin J Am Soc Nephrol (2008) 1.43
Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study). Eur Radiol (2012) 1.42
[Kidney and HIV infection]. Presse Med (2012) 1.39
Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am J Pathol (2008) 1.38
Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. Am J Med Genet A (2010) 1.31
D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am J Kidney Dis (2007) 1.24
Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis (2011) 1.23
Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis (2007) 1.22
Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Mol Carcinog (2003) 1.19
The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res (2005) 1.19
Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease. BMC Nephrol (2012) 1.16
MMP9 and SCF protect from apoptosis in acute kidney injury. J Am Soc Nephrol (2009) 1.16
High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int (2004) 1.15
Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores. Hum Mutat (2008) 1.14
Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis (2004) 1.14
Renal involvement in Castleman disease. Nephrol Dial Transplant (2010) 1.13
PPARgamma activation enhances cell surface ENaCalpha via up-regulation of SGK1 in human collecting duct cells. FASEB J (2003) 1.13
c-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal (2010) 1.12
Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome. Clin J Am Soc Nephrol (2009) 1.10
Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol (2011) 1.10
Onco-nephrology: glomerular diseases with cancer. Clin J Am Soc Nephrol (2012) 1.09
Redox-induced surface stress of polypyrrole-based actuators. J Phys Chem B (2005) 1.09
Fetomaternal alloimmunization with antenatal glomerulopathies. Ann N Y Acad Sci (2007) 1.09
The role of cell plasticity in progression and reversal of renal fibrosis. Int J Exp Pathol (2011) 1.08
Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy. Nat Rev Nephrol (2011) 1.08
Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. Kidney Int (2011) 1.07
Timing and determinants of erythropoietin deficiency in chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.05
Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studies. J Clin Endocrinol Metab (2005) 1.05
Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol (2008) 1.04
Pemetrexed-induced acute kidney injury leading to chronic kidney disease. Clin Nephrol (2014) 1.02
Immunoglobulin deposition disease with a membranous pattern and a circulating monoclonal immunoglobulin G with charge-dependent aggregation properties. Am J Kidney Dis (2010) 1.01
Association of PKD2 (polycystin 2) mutations with left-right laterality defects. Am J Kidney Dis (2011) 1.01
A case of phospholipase A₂ receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am J Kidney Dis (2010) 1.01
HIV-associated kidney glomerular diseases: changes with time and HAART. Nephrol Dial Transplant (2012) 1.00
Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. FASEB J (2012) 0.99
Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine (Baltimore) (2009) 0.99
Progression and regression in renal vascular and glomerular fibrosis. Int J Exp Pathol (2004) 0.99
Role of extracellular matrix in kidney development and repair. Pediatr Nephrol (2003) 0.99
Renal granulomatoses: a retrospective study of 40 cases and review of the literature. Medicine (Baltimore) (2007) 0.99
Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis. J Pathol (2010) 0.97
Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss. Am J Kidney Dis (2008) 0.97
Neuropathology of holoprosencephaly. Am J Med Genet C Semin Med Genet (2010) 0.96
Autosomal-dominant familial hematuria with retinal arteriolar tortuosity and contractures: a novel syndrome. Kidney Int (2005) 0.94
Evidence of follicular T-cell implication in a case of IgG4-related systemic disease with interstitial nephritis. Nephrol Dial Transplant (2011) 0.94
Giant cell arteritis presenting as a breast lesion: report of a case and review of the literature. Am J Med Sci (2008) 0.94
Rhinoscleroma of the sinuses. Rhinology (2008) 0.94
A complete analysis of the laser beam deflection systems used in cantilever-based systems. Ultramicroscopy (2006) 0.94
Precise control of the size and noise of solid-state nanopores using high electric fields. Nanotechnology (2012) 0.94
Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study. Clin J Am Soc Nephrol (2013) 0.94
Immunopathogenesis of membranous nephropathy: an update. Semin Immunopathol (2014) 0.94
Glomerular lesions in patients with sickle cell disease. Medicine (Baltimore) (2010) 0.93
Renal biopsy practice in France: results of a nationwide study. Nephrol Dial Transplant (2010) 0.93
Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. Eur J Endocrinol (2005) 0.92
Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med (2002) 0.92
Hyaluronidase is more elevated in human brain metastases than in primary brain tumours. Anticancer Res (2002) 0.91
Notch3 is essential for regulation of the renal vascular tone. Hypertension (2011) 0.91
A combination of cis-acting elements is required to activate the pro-alpha 1(I) collagen promoter in tendon fibroblasts of transgenic mice. J Biol Chem (2002) 0.90
Dysferlin deficiency treated like refractory polymyositis. Clin Rheumatol (2010) 0.90
GFR estimation using the Cockcroft-Gault, MDRD study, and CKD-EPI equations in the elderly. Am J Kidney Dis (2012) 0.90
Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction. Kidney Int (2012) 0.89